How Articles in Press Are Changing the Speed of Modern Science Publishing

Every day, thousands of newly accepted research papers appear online before they are officially published, carrying a label that many readers overlook but that has become one of the most consequential innovations in modern scientific communication: Article in Press. The concept is deceptively simple. Once a manuscript has been formally accepted by a journal’s editors after peer review, it can be posted online immediately in an early-access form, complete with its own permanent Digital Object Identifier, or DOI. That identifier functions like a digital fingerprint, allowing the paper to be viewed, shared, and cited by researchers around the world long before the final typeset version appears. For a field such as pharmacology and toxicology, where findings about drug safety and toxicity can influence clinical decisions and regulatory policy, the difference of weeks or months between acceptance and formal publication can matter enormously.

The mechanics behind the Article in Press model reveal how deeply digital infrastructure has reshaped the economics and tempo of scholarly publishing. In the traditional print-era workflow, a paper accepted by a journal would wait in a queue for an issue to be assembled, typeset, printed, and distributed, a process that could consume several months. The early-access approach decouples acceptance from publication. The accepted, peer-reviewed manuscript is posted as submitted or lightly processed, clearly labelled online to show that it is not the final Version of Record. Because the DOI is assigned at this stage, citations accumulate from the moment the paper becomes visible, and the citation record carries forward seamlessly: when the final Version of Record is published, it replaces the Article in Press under the same DOI, so no reference ever breaks.

That permanence of the identifier is more than a technical convenience. It solves a problem that plagued early experiments with online-first publishing in the late 1990s and 2000s, when preliminary web versions sometimes carried different identifiers or no identifiers at all, fragmenting the citation trail. Under the current model, the DOI acts as a stable thread running through every stage of a paper’s life. A researcher who cites the Article in Press version today is citing the same object that will exist as the Version of Record tomorrow. This continuity matters for meta-analyses, systematic reviews, and clinical guidelines, all of which depend on citation records that remain coherent over decades.

The system is not without caveats, and the journals that use it are explicit about them. An Article in Press may be subject to further editing, because errors affecting the content can be discovered during the final production process. Errors in the early-access version are corrected during the author proofing stages of production, and those corrections are reflected in the final Version of Record. In practice, this means the version a reader encounters online immediately after acceptance is a snapshot of the peer-reviewed manuscript, not a polished, typeset artifact. Figures may be reformatted, references may be rechecked, and copyediting may adjust phrasing. The scientific substance has passed peer review, but the presentation is still in transit.

For readers, the labelling is the critical safeguard. Every Article in Press is clearly marked online to indicate that it is not the final Version of Record, and all legal disclaimers relating to the journal apply to it. This transparency matters most in fast-moving or high-stakes fields. In pharmacology and toxicology, where a single paper on a drug’s toxicity profile can be picked up by clinicians, journalists, and regulators within hours of appearing online, the distinction between a peer-reviewed but not-yet-final manuscript and a fully published Version of Record is a meaningful one. The labelling system exists precisely so that downstream users can weigh the evidence appropriately, understanding that the peer-review filter has already been applied even though production remains incomplete.

The open-access dimension adds another layer of significance. Fully open-access journals provide this early-access service on every accepted manuscript, meaning that no accepted paper waits behind a production queue before becoming publicly visible. This has a democratizing effect on the speed of science. A researcher in a low-resource setting, a clinician in a community hospital, or a journalist covering a public health story can all access the accepted findings at the same moment as researchers at elite institutions. The traditional lag between acceptance and publication, which once created an information asymmetry favoring those with library access to the fastest journals, is effectively eliminated at the moment of acceptance.

Behind the scenes, the workflow that makes this possible involves a coordinated sequence of editorial and production steps. Once peer review concludes and the editors issue a formal acceptance, the manuscript enters the production pipeline. The Article in Press version is generated from the accepted files, assigned its DOI, and posted to the journal’s online platform. Author proofing then begins, in which the authors review the typeset version and flag errors. Corrections discovered at this stage are folded into the Version of Record. The process acknowledges a simple truth about scholarly publishing: even after peer review, the transformation of a manuscript into a finished published article involves human steps that can introduce or reveal errors, and the early-access model builds in a visible, correctable intermediate state rather than pretending the first online appearance is flawless.

For authors, the practical implications are significant. An accepted paper begins accruing citations, visibility, and potential media attention immediately, which can matter for grant applications, tenure timelines, and career progression. But authors also carry a responsibility during the proofing stage, because errors they fail to catch will persist into the Version of Record. Journals that use the Article in Press model typically encourage authors organizing press releases to contact their production editor as early as possible, ensuring that media coverage aligns with the availability and status of the paper. The coordination between publicity and publication status is a small but telling detail: it reflects an awareness that early-access papers enter the public sphere before they are finalized, and that communication about them should reflect that status honestly.

The broader significance of the Article in Press model lies in what it reveals about the changing tempo of science itself. Research in areas such as infectious disease, toxicology, and pharmacology increasingly unfolds on timelines measured in weeks, not years, and the publishing ecosystem has adapted accordingly. The early-access approach preserves the essential checkpoints of peer review and formal publication while removing the artificial delay between them. It treats the DOI as the permanent anchor of a paper’s identity and treats the published record as a sequence of improving versions rather than a single fixed event. For readers, the takeaway is straightforward but important: when you encounter a paper labelled as an Article in Press, you are looking at peer-reviewed science that has been accepted and made permanently citable, but not yet finalized. The findings are real and reviewable, the identifier is stable, and the final version will arrive under the same DOI, correcting any residual errors along the way. In an era when the speed of dissemination shapes the pace of discovery, that combination of immediacy and transparency has quietly become one of the most important infrastructures in scientific communication.

Subject of Research: Early-access publishing of accepted peer-reviewed manuscripts as Articles in Press with permanent DOIs

Article Title: Articles in Press

Article References: Articles in Press. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Article in Press, peer review, DOI, open access, scholarly publishing, Version of Record, pharmacology, toxicology, scientific communication, early access, citation, BMC